Top Markets
Coin of the day
Anbio Biotechnology Class A Ordinary Shares Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology Class A Ordinary Shares

NNNN
Ранг среди акций #16102
Anbio Biotechnology, established in 2021 and based in Frankfurt am Main,... Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers regions such as the European Union, Asia Pacific, North America, South America, and Africa. Their product range features various diagnostic solutions, including rapid antigen tests for SARS-CoV-2 (both individual and combined with influenza A/B). Anbio also develops and manufactures products leveraging advanced technologies like lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification (LAMP), chemiluminescence immunoassay (CLIA), and reverse-transcription polymerase chain reaction (RT-PCR). These offerings cater to a wide array of markets, including over-the-counter sales, point-of-care testing, and traditional laboratory settings.
Цена акции
$7.15
Рыночная капитализация
$313.60M
Изменение (1 день)
-2.12%
Изменение (1 год)
-84.14%
Страна
DE
Торговля Anbio Biotechnology Class A Ordinary Shares (NNNN)

Категория

EPS для Anbio Biotechnology Class A Ordinary Shares (NNNN)
EPS по состоянию на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Anbio Biotechnology Class A Ordinary Shares, текущий EPS компании (TTM) составляет 0. В конце 2026 EPS компании составлял 0, равна показателю 2026 года, равному 0.
История EPS компании Anbio Biotechnology Class A Ordinary Shares с 2026 по 2026
EPS на конец каждого года
Год EPS Изменить
Недостаточно данных для указанных дат.
EPS для аналогичных компаний или конкурентов
Компания EPS Разница в EPS Страна
$8.85 -
US
$6.41 -
FR
- -
JP
$3.32 -
US
- -
CH